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We examined 66 cats with salinomycin intoxication. Salinomycin caused diﬀe r e n tL M Ns i g n so fv a r y i n gd e g r e e so fs e v e r i t y
in all cases. Changes in blood work were unspeciﬁc, with the most frequent being increased serum creatine kinase activity,
leukocytosis, and increased liver enzymes. Pathological electrodiagnostic ﬁndings: ﬁbrillation potentials and positive sharp waves
were detected in 10 cases, motor nerve conductance velocity was mildly decreased in 8/12 cats, and sensory nerve conductance
velocity and repetitive nerve stimulation were normal in all examined cases. In ﬁve cases the peripheral neuropathy was conﬁrmed
by pathohistology. Fluid therapy and supportive care were used as therapy and 52 cats recovered completely. The probability for
complete remission was signiﬁcantly diﬀerent between mildly and severely aﬀected cases. It seems that the severity of clinical
signs and prognosis correlate well with the amount of toxin ingested. We conclude that early recognition and decontamination
combined with supportive care results in complete recovery.
1.Introduction
In spring 1996 there was an outbreak of salinomycin-related
neurological dysfunction in cats in the Netherlands and
Switzerland. Epidemiological information on the aﬀected
cats indicated that this outbreak was related to the feeding
of two brands of dry food from one manufacturer and was
caused by contamination of the food with the coccidiostatic
drug salinomycin. The clinical signs ranged from mild para-
paresis to severe tetraparesis with autonomic dysfunction.
Salinomycin is a monovalent ionophore and is used as
a coccidiostatic drug in poultry and as a growth promoter
in chickens, pigs, and cattle. Ionophores can cause toxicosis
in nontarget species, however, it has been reported in sheep
[1], pigs [2], horses [3, 4], dogs [5], and cats [6]. Salino-
mycin forms a lipid-soluble complex with cations and can
cause loss of intracellular potassium, which results in ATP
inhibition, cell energy depletion and consequently cell death
[7]. The clinicopathological changes most often reported
include RBC fragility, electrolyte disturbances, CK elevation,
and myoglobinuria. Pathological changes are found in the
myocardium, skeletal muscle, and peripheral nerves [8].
Although the toxicity of salinomycin is well known, there
are no detailed studies on clinical, neurological, laboratory
and electrophysiological ﬁndings in cats. The aim of this
study was to describe retrospectively the historical, clinical,
laboratory, and electrophysiological data as well as outcome
in cats with salinomycin intoxication.
2.MaterialandMethods
Sixty-six well-documented medical records of cats with
clinical signs of polyneuropathy caused by the presence
of salinomycin in two diﬀerent brands of commercial cat2 Veterinary Medicine International
Table 1: Clinical signs, onset, type and amount of food from cats of groups no.1–6.
Group Clinical signs Number of cases Days prior to clinical signs Only Amount
total n = 66 acute n = 50 chronic n = 16 min max mean Food I or II. min max
1 LMN Paraparesis 19 18 1 4 5 4.5 19 33 100
2 LMN Paraplegia 23 20 3 5 7 6 22 20 100
3 LMN Tetraparesis 11 7 4 3 10 4.5 11 25 150
4L M N T e t r a p l e g i a 5 3 2 47 4.5 5 15 100
5 LMN Tetraplegia, cranial
nerve deﬁcits, and dyspnoea 50 5 4 10 6 5 20 100
6 Vestibular syndrome and
autonomic signs 32 1 5 15 6 2 33 150
min: minimum; max: maximum; LMN: lower motor neuron disease; Food I and Food II: two diﬀerent brands of commercial cat food contaminated with
salinomycin; Amount: Amount of food expressed in percentile (100% = one can).
food (Food I and Food II) were selected and reviewed.
The study population included 54 cases reported by referral
vets and 12 cases admitted to the Small Animal Teaching
Hospital of the University of Bern during May 1997. All
cats were subjected to a complete physical and neurolog-
ical examination. The cats were classiﬁed into six groups
according to their neurological status (Table 1). In two thirds
of the cases additional laboratory investigations including
complete blood cell counts (CBC), blood chemistry, elec-
trolyte evaluation, as well as urinalysis were performed.
Cerebrospinal ﬂuid (CSF) analysis (n = 13) included total
white cell count, cytomorphology, protein determination,
and Pandy reaction. In selected cases, clinical electrophysi-
ological tests were carried out including electromyography
(EMG), motor nerve conduction velocity (MNCV), sensory
nerve conduction velocity (SNCV), and repetitive nerve
stimulation testing (RNS). Two cats had serial EMG and
NCV tests to follow the course of the disease. Clinical
electrophysiological tests were performed under general
anaesthesia. Cats were premedicated with medetomidine
(Domitor, Orion Corp. Farmos, Turku, SF; 0.025mg/kg
body weight (BW)) and anaesthesia was induced with
intravenous bolus of propofol (Disoprivan, Zeneca Ltd.,
Macclesﬁeld, Cheshire, UK; 1mg/kg BW, IV) until eﬀect.
The cats were then intubated and oxygen was administered.
Finally, medetomidine was antagonized with atipamezol
(Antisedan, Orion Corp. Farmos, Turku, SF; 0.0625mg/kg
BW, IV). Clinical electrophysiological tests were recorded
using two-channel equipment (Dantec Cantata; Dantec).
Stimulation and recording cables (Dantec 13 PO2/12 and
Dantec 13 L01, respectively). and recording and stimulation
electrodes (Dantec 9013 L0492 and Monopolar 13 R 11
Dantec. respectively) were used as described previously
[9]. The MNCV of the left peroneal nerve between the
trochanter major and the popliteal fossa was assessed by
the onset-latency method. The recording concentric needle
was inserted into the motor point of the cranial tibial
muscle and two pairs of stimulating electrodes were placed
perpendicularly to the peroneal nerve in the trochanteric
and popliteal fossa [10]. The position of the stimulating
electrodes was optimized until Compound Motor Action
Potential (CMAP) with maximal amplitude was obtained at
1.5-to2.5-milliampere(mA)stimulationcurrent.TheSNCV
and RNS of the left peroneal nerve were assessed as described
by Redding et al. [11].
Peroneal nerve (n = 7) and cranial tibial muscle biopsies
were performed in selected cases (n = 7) and a postmortem
examination was available in ﬁve cats.
I no r d e rt oc o m p a r ed i ﬀerent diagnostic parameters
between clinical groups, the initial categories (Groups) 1 and
2 and 3–5 were combined in order to increase the number
of animals in the comparison groups. Animals in Group 6
were omitted since they belonged to another clinical entity.
Subsequently a Fisher’s Exact Test (2-sided) was used to
statistically assess the association between the clinical score
and other disease-related parameters.
3. Results
Thirty-two male and 34 female cats were included, ranging
in age from 6 months to 11 years. Sixty-four European
shorthaired cats, one Siamese, and one Manx cat were
studied. Lower motor neuron (LMN) disease was present
in all cases. The neurological examination showed LMN
paraparesis (Group 1, n = 19), LMN paraplegia (Group
2, n = 23), LMN tetraparesis (Group 3, n = 11), LMN
tetraplegia (Group 4, n = 5), LMN tetraplegia, cranial nerve
deﬁcits with dyspnoea (Group 5, n = 5), and vestibular
syndrome with autonomic signs (Group 6, n = 3) (Table 1).
Acute onset (1–3 days duration) was documented in 50 cases
and subacute onset (more than 3 days) in 16 cases. The
chronic cases had a higher probability of developing more
severe clinical signs (Table 4). Blood work was abnormal
in 20/42 cases. The most common change was increased
serum creatine kinase (CK) activity (n = 17), leukocytosis
with mild left shift (n = 11), and increased liver enzymes
(n = 9). Cats in the more severely aﬀected groups showed
more frequent changes in the serum biochemistry (9/17
in Groups 3–5) than those in less severely aﬀected groups
( 5 / 2 3i nG r o u p s1a n d2 ) .T h i sd i ﬀerence was signiﬁcant
(P = .0011) (Table 4). Electromyography was carried out in
16 cats. Pathological ﬁndings such as ﬁbrillation potentials
and positive sharp waves were detected in 10 cases. Extensor
and ﬂexor muscles were involved with equal distribution.Veterinary Medicine International 3
Table 2: Number of electrodiagnostic test nerve biopsies from cats of groups no.1–6.
Group
Electrodiagnostic Tests Nerve Biopsy
EMG MNCV SNCV RNS
Number of Cases Number of Cases Number of Cases Number of Cases Number of Cases
total norm. abn. total norm. abn. total norm. abn. total norm. abn. total norm. abn.
1 440 220 000 000 110
2 523 321 110 000 110
3 303 303 220 330 101
4 202 202 220 220 202
5 202 202 220 220 202
6 000 000 000 000 000
Total 16 6 10 12 4 8 8 8 0 7 7 0 7 2 5
norm.:normal;abn.:abnormal;EMG:electromyography;MNCV:motornerveconductionvelocity;SNCV:sensorynerveconductionvelocity;RNS:repetitive
nerve stimulation; Group 1: LMN paraparesis; Group 2: LMN paraplegia; Group 3: LMN tetraparesis; Group 4: LMN tetraplegia; Group 5: LMN tetraplegia,
cranial nerve deﬁcits and dyspnoea; Group 6: vestibular syndrome and autonomic signs.
Table 3: Therapy and outcome from cats of groups no. 1–6 (recovery rate and time).
Group
Therapy Recovered
Total Number Infusion Ringer-Lactated Food I. Food II. Complete recovery died Recovery Time (Days)
of Cases Penicillin total rec. total rec. min max
1 19 iv for 2 d 17 15 2 2 17 0 51 0
2 23 sc for 2-3 d 21 20 2 2 22 0 71 5
3 1 1 i vf o r2 - 3d 1 1 7 0 0 7 0 71 6
45 i v f o r 5 – 7 d 5 3 0 0 30 14 28
55 — 5 0 0 0 05 ——
63 i v f o r 2 - 3 d 3 3 0 0 30 10 15
Total 66 — 62 48 4 4 52 5 52 8
rec.: recovered; min: minimum; max: maximum: sc: subcutaneously; iv: intravenously; Food I and Food II: two diﬀerent brands of commercial cat food
contaminated with salinomycin; Group 1: LMN paraparesis; Group 2: LMN paraplegia; Group 3: LMN tetraparesis; Group 4: LMN tetraplegia; Group 5:
LMN tetraplegia, cranial nerve deﬁcits, and dyspnoea; Group 6: vestibular syndrome and autonomic signs.
Proximal muscles were more aﬀected than distal muscles,
and hind limbs (bilateral) more than fore limbs. The MNCV
was 70m/s so interpreted as mildly decreased in 8/12 cats
[12], the SNCV was normal in all 8 cats examined, and
RNS was normal in all 7 examined cats (Table 3). The
EMG and MNCV were repeated in 2 cases with similar
ﬁnding to the previous. The electrophysiological changes
were signiﬁcantly more frequent in Groups 3–5 than in
Groups 1 and 2 (Table 4). Nerve biopsy was taken in seven
cases and revealed a peripheral neuropathy in ﬁve cats
(Figure 1). Axonal swelling, fragmentation, axonal loss, and
digestion chamber formation were consistent with salino-
mycin toxicity, as described previously by Van der Linde-
Sipman et al. [6]( Table 2.). The peripheral neuropathy
was conﬁrmed by biopsy only in Groups 3–5. The CSF
analysis was available in Groups 1–5 and was unremarkable
in all 13 examined cases. The mean duration of feeding
on food containing salinomycin was 4.5 to 6 days in all
groups. The majority of cases (64/66) were exclusively fed
with this food. The daily intake of food was diﬀerent and
ranged between 1/6 and 1 1/2tins (Table 1). As salinomycin
does not have a speciﬁc antidote, the therapy was ﬂuid
therapy (Lactated Ringer Solution, two maintenance doses)
and supportive care. Urination was accomplished by manual
expression of the bladder as necessary; a faecal softener was
used if constipation occurred. Soft bedding and frequent
position changes were performed in recumbent cats. Daily
physiotherapy included massage, passive joint-movement,
and gait exercise, as described previously by Jaggy and
Kathmann [13]. The duration of recovery was diﬀerent
between the groups. The number of cats with complete
recovery was 52. All cases (n = 5) that did not survive
were severely ill and belonged to Group 5. Nine cats had
persistent neurological signs. The probability for complete
remission was signiﬁcantly diﬀerent between Groups 1 and
2 and Groups 3–5 (P = .0002) (Table 4). The recovery time
was diﬀerent between the groups with a marked contrast
between the mild (Groups 1 and 2) and severe (Groups 3–
5) cases. The clinical outcome is summarized in Table 3.
4. Discussion
We examined 66 cats with salinomycin intoxication. Sali-
nomycin caused diﬀerent LMN signs of varying degrees of
severity in all cases. There were no clinical signs of CNS4 Veterinary Medicine International
Table 4: Association between various parameters from cats of
groups no. 1+2 and 3–5 and clinical scores expressed as the P-value.
Parameter Groups Groups P-value
1+2 3+4+5
combined combined (Fisher’s Exact Test)
Acute 38 10 .0004
Chronic 4 11
Normal blood/urin 16 3 .0011
Abnormal
blood/urin 61 4
EMG Normal 6 0 .0114
EMG Abnormal 3 7
MNCV Normal 4 0 .0101
MNCV Abnormal 1 7
Biopsy Normal 2 0 .0476
Biopsy Abnormal 0 5
Recovered 39 13 .0002
Not Recovered 3 11
Group 1: LMN paraparesis; Group 2: LMN paraplegia; Group 3: LMN
tetraparesis; Group 4: LMN tetraplegia, Group 5: LMN tetraplegia; cranial
nerve deﬁcits, and dyspnoea; Group 6: vestibular syndrome and autonomic
signs.
involvement or abnormal CNS ﬁndings on pathological
examination in our cats, a similar ﬁnding to that reported
previously in horses [4].
It has been shown that high doses of salinomycin can
cause death within minutes. Clinical signs usually develop
within a few hours to days after ingestion [4, 5, 8]. This was
consistent with our observations. Most cases (50/66) had an
acute onset and became abnormal within three days. The
LMN signs in the present study are not surprising in the
light of a previous report in which peripheral neuropathy
characterizedbyprimaryaxonaldegenerationandsecondary
degeneration of the myelin sheath was conﬁrmed [6]. The
clinical signs, which varied from paraparesis to tetraplegia,
were bilateral, symmetrical, and progressed from the pelvic
t ot h o r a c i cl i m b s .I ns o m ec a t s( n = 5, Group 5)
cranial nerves were aﬀected and some cats were dyspnoeic.
Interestingly, dyspnoea was observed only in combination
with severe tetraplegia. Respiratory problems were found
in 7/10 dogs with ionophore intoxication [5](Safran et al.
1993) and were reported to be the main cause of death or
euthanasia in cats with salinomycin intoxication [6].
Leucocytosis was observed in 12/42 cats and was con-
sidered to be stress-related, resembling previous ﬁndings in
horses [4]. The observed CK elevation (17 cats) suggests
enzyme leakage from secondary damaged muscle ﬁbrils
and is most likely to originate from skeletal muscle and
myocardium. Myocardial degeneration was observed in all
cats; focal hyaline degeneration of the skeletal muscula-
ture was previously seen occasionally in cats with sali-
nomycin intoxication [6]. Mildly increased liver enzymes
were thought to be due to unspeciﬁc signs of intoxication
as ionophores are metabolized by the liver and the liver
Figure 1: Peripheral nerve, cat. Wallerian type degeneration
characterized by digestion chambers containing fragmented axons,
degenerated myelin and numerous foamy macrophages. Schwann
cells are swollen. Hematoxylin & Eosin, 400×.
is the primary site of ionophore storage. Increased liver
enzymes and myoglobinuria have been detected in horses
and humans with ionophore poisoning [14]. However, the
latter was not found in our cases. The small number
of cases subject to electrophysiological testing does not
allow objective conclusions but it seems to be a tendency
that in more severe (and chronic) cases more pronounced
electrodiagnostic changes were recorded. They were mainly
seen as denervation potentials (EMG changes) and mildly
decreased MNCV which suggest more axonal involvement.
Salinomycin chelates monovalent cations which facilitates
cation cell membrane transport inﬂuence the electrical
potential and energy metabolism which is the basic of
toxicologic eﬀect [8]. This may primarily aﬀects axons and
only secondarily Schwann cells.
These changes were signiﬁcantly more frequent in
Groups 3–5 than in Groups 1 and 2 (Tables 2 and 4). The
SNCV was normal in all examined cases, which suggests
that the motor part of the nerve (motor neuropathy) was
mainly aﬀected by intoxication. This ﬁnding contradicts a
previous report in which both sensory and motor nerves
were reported to be aﬀected [6] .T h en o r m a lR N Si n
all cases suggests that the function of the neuromuscular
junction was not impaired. The nerve biopsy diagnosed
peripheral neuropathy in all cases of Groups 3–5 but it was
normal in Groups 1 and 2. However, the small number
of cats examined hinders more solid conclusions. The lack
of pathological changes in more mildly aﬀected cases may
be related to functional nerve conduction disturbance with
mild or no morphological changes [8]. The prognosis in
animals with salinomycin poisoning varies. It seems that
there is a marked diﬀerence of susceptibility to ionophores
between species. Dogs and horses may be more sensitive
than other animals [5] .T h em a j o r i t y( 7 9 % )o fa ﬀected cats
recovered with supportive care and physiotherapy. Among
the severely aﬀected cats (Groups 3–5) the recovery rateVeterinary Medicine International 5
was signiﬁcantly lower and the recovery time longer than in
Groups 1 and 2 (Table 8). All ﬁve cats in Group 5 died. No
lethal cases were observed in the other groups. It seems that
tetraplegia and impairment of cranial nerves and dyspnoea
are connected with a grave prognosis in cats with salino-
mycin intoxication. On the other hand, tetraplegic animals
in which the cranial nerves and breathing function were not
impaired all recovered. Artiﬁcial ventilation may have been
of therapeutic beneﬁt in cats with dyspnoea as the peripheral
neuropathyimpairedthefunctionoftherespiratorymuscles.
Intermittent positive pressure ventilation was reported to be
successful in dogs. In the respective report, all 10 aﬀected
dogs survived and showed full recovery. The recovery time
takes 2–50 days depending on the severity of the case [5].
In conclusion, we have reported detailed clinical–
pathological data of salinomycin intoxication in cats and
provided useful information on the prognosis of aﬀected
animals. It seems that the severity of clinical signs and
prognosis correlate well with the amount of toxin ingested,
although individual variations might be present. The aim of
this paper is also to draw clinicians attention to the danger
of ionophores (salinomycin, monensin, and lasalocid) and
to include this toxic polyneuropathy in the list of possible
diﬀerential diagnoses in cats with LMN tetraparesis or
tetraplegia.
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